Literature DB >> 12648943

Will the enigma of Francisella tularensis virulence soon be solved?

Richard W Titball1, Anders Johansson, Mats Forsman.   

Abstract

Francisella tularensis is one of the most infectious bacterial pathogens known and is the causative agent of the zoonotic disease tularemia. In spite of the importance of this pathogen little is known about its virulence mechanisms. However, it is clear that the bacterium is an intracellular pathogen, replicating mainly in macrophages, with replication in amoebae also having been reported. The genome sequence of a high virulence strain of F. tularensis is close to completion and when available, will stimulate further research into virulence mechanisms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12648943     DOI: 10.1016/s0966-842x(03)00020-9

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  29 in total

1.  Detection of diverse new Francisella-like bacteria in environmental samples.

Authors:  Susan M Barns; Christy C Grow; Richard T Okinaka; Paul Keim; Cheryl R Kuske
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

2.  Intranasal interleukin-12 treatment promotes antimicrobial clearance and survival in pulmonary Francisella tularensis subsp. novicida infection.

Authors:  Michael A Pammit; Varija N Budhavarapu; Erin K Raulie; Karl E Klose; Judy M Teale; Bernard P Arulanandam
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

3.  Formulation and stabilization of Francisella tularensis live vaccine strain.

Authors:  Satoshi Ohtake; Russell A Martin; Atul Saxena; David Lechuga-Ballesteros; Araceli E Santiago; Eileen M Barry; Vu Truong-Le
Journal:  J Pharm Sci       Date:  2011-04-13       Impact factor: 3.534

4.  The presence of infectious extracellular Francisella tularensis subsp. novicida in murine plasma after pulmonary challenge.

Authors:  J-J Yu; E K Raulie; A K Murthy; M N Guentzel; K E Klose; B P Arulanandam
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12-18       Impact factor: 3.267

5.  In silico prediction of human pathogenicity in the γ-proteobacteria.

Authors:  Massimo Andreatta; Morten Nielsen; Frank Møller Aarestrup; Ole Lund
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

6.  A comprehensive transposon mutant library of Francisella novicida, a bioweapon surrogate.

Authors:  Larry A Gallagher; Elizabeth Ramage; Michael A Jacobs; Rajinder Kaul; Mitchell Brittnacher; Colin Manoil
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-10       Impact factor: 11.205

7.  Construction and characterization of a highly efficient Francisella shuttle plasmid.

Authors:  Tamara M Maier; Andrea Havig; Monika Casey; Francis E Nano; Dara W Frank; Thomas C Zahrt
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

8.  Oral live vaccine strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A.

Authors:  Heather J Ray; Yu Cong; Ashlesh K Murthy; Dale M Selby; Karl E Klose; Jeffrey R Barker; M Neal Guentzel; Bernard P Arulanandam
Journal:  Clin Vaccine Immunol       Date:  2009-02-11

9.  Worldwide genetic relationships among Francisella tularensis isolates determined by multiple-locus variable-number tandem repeat analysis.

Authors:  Anders Johansson; Jason Farlow; Pär Larsson; Meghan Dukerich; Elias Chambers; Mona Byström; James Fox; May Chu; Mats Forsman; Anders Sjöstedt; Paul Keim
Journal:  J Bacteriol       Date:  2004-09       Impact factor: 3.490

Review 10.  Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development.

Authors:  Roger D Pechous; Travis R McCarthy; Thomas C Zahrt
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.